Baldwin Brothers LLC Beyond Air, Inc. Transaction History

Baldwin Brothers LLC

$1.45 Billion
Q3 2025

A detailed history of Baldwin Brothers LLC transactions in Beyond Air, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 15,400 shares of XAIR stock, worth $21,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,400

Previous 308,000 95.0%

Holding current value

$21,560

Previous $52,000 30.77%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 14, 2025	SELL	$0.17 - $4.2 $49,742 - $1.23 Million	-292,600 Reduced 95.0%	15,400 $36,000
Q4 2024 Jan 22, 2025	BUY	$0.3 - $0.67 $81,150 - $181,235	270,500 Added 721.33%	308,000 $110,000
Q4 2023 Jan 08, 2024	SELL	$1.4 - $2.46 $700 - $1,230	-500 Reduced 1.32%	37,500 $73,000
Q1 2023 Apr 21, 2023	BUY	$5.65 - $7.56 $56,500 - $75,600	10,000 Added 35.71%	38,000 $256,000
Q4 2022 Jan 27, 2023	SELL	$5.47 - $7.9 $95,725 - $138,250	-17,500 Reduced 38.46%	28,000 $0

Q1 2022 Apr 13, 2022	BUY	$6.33 - $9.53 $31,650 - $47,650	5,000 Added 12.35%	45,500 $304,000
Q4 2021 Jan 14, 2022	BUY	$8.44 - $15.61 $29,540 - $54,635	3,500 Added 9.46%	40,500 $382,000
Q3 2021 Oct 27, 2021	BUY	$5.9 - $12.54 $106,200 - $225,719	18,000 Added 94.74%	37,000 $411,000
Q2 2021 Jul 30, 2021	SELL	$4.72 - $7.15 $35,400 - $53,625	-7,500 Reduced 28.3%	19,000 $123,000
Q1 2021 Apr 08, 2021	SELL	$5.13 - $7.24 $10,260 - $14,480	-2,000 Reduced 7.02%	26,500 $146,000
Q3 2020 Oct 16, 2020	BUY	$4.86 - $7.07 $31,590 - $45,955	6,500 Added 29.55%	28,500 $148,000
Q2 2020 Jul 21, 2020	BUY	$6.44 - $9.45 $38,640 - $56,699	6,000 Added 37.5%	22,000 $160,000
Q1 2020 Apr 15, 2020	BUY	$3.94 - $10.93 $63,040 - $174,880	16,000 New	16,000 $128,000

Others Institutions Holding XAIR

# of Institutions

Shares Held

657K

Call Options Held

Put Options Held

View Full List

About Beyond Air, Inc.

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $41.8M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

More about XAIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Beyond Air, Inc. Transaction History